JANE STREET GROUP, LLC

Position in DARE — Dare Bioscience, Inc.

CIK 1595888 NEW YORK, NY

Position in DARE

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$76,153

+$55,775 QoQ

Shares Held

36,092

+241.8% QoQ

Ownership

0.236%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

of 27 holders

Holding Since

Sep 2021

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

JANE STREET GROUP, LLC holds $1,373,713,627 across 292 Biotechnology names. DARE ranks #219 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BBIO	BridgeBio Pharma, Inc.	2,934,193	$218,538,693
2	MDGL	Madrigal Pharmaceuticals, Inc.	191,541	$102,847,939
3	AXSM	Axsome Therapeutics, Inc.	403,995	$98,885,855
4	TGTX	Tg Therapeutics, Inc.	1,752,646	$96,290,370
5	EXEL	Exelixis, Inc.	1,402,438	$76,306,651
6	QURE	uniQure N.V.	1,610,483	$74,178,846
7	HALO	Halozyme Therapeutics, Inc.	694,684	$54,372,915
8	TVTX	Travere Therapeutics, Inc.	938,699	$53,327,489

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$76,153	36,092	+241.8%	Shares	Defined	2026-08-14
2025-12-31	$20,378	10,559	-36.3%	Shares	Defined	2026-02-12
2024-12-31	$51,742	16,584	+48.8%	Shares	Defined	2025-02-14
2024-06-30	$3,744	11,145	-5.2%	Shares	Defined	2024-08-15
2024-03-31	$5,760	11,757	-53.0%	Shares	Defined	2024-05-16
2023-09-30	$11,554	25,009	-66.8%	Shares	Defined	2023-11-15
2023-03-31	$78,355	75,342	+240.0%	Shares	Defined	2023-05-16
2022-12-31	$18,394	22,162	-62.2%	Shares	Defined	2023-02-15
2022-03-31	$87,324	58,607	+2.2%	Shares	Defined	2022-05-17
2021-12-31	$114,709	57,355	-68.4%	Shares	Defined	2022-02-15
2021-09-30	$303,241	181,582	—	Shares	Defined	2021-11-16
No filing history on record for this holder in this stock.